Olezarsen
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Olezarsen, covering 2024-05-10 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia [Phase 2]